|
WO2021071983A1
|
|
Compounds for modulating splicing
|
|
WO2021071984A1
|
|
Compounds for modulating splicing
|
|
WO2021071981A1
|
|
Compounds for modulating splicing
|
|
WO2021071982A1
|
|
Compounds for modulating splicing
|
|
WO2020190793A1
|
|
Compositions and methods for correction of aberrant splicing
|
|
US2020390765A1
|
|
Methods for modulating splicing
|
|
WO2020163647A1
|
|
Methods and compositions for modulating splicing
|
|
WO2020163544A1
|
|
Methods and compositions for modulating splicing
|
|
WO2020163541A1
|
|
Methods and compositions for modulating splicing
|
|
WO2020163406A1
|
|
Methods and compositions for modulating splicing
|
|
WO2020163382A1
|
|
Methods and compositions for modulating splicing
|
|
WO2020163401A1
|
|
Methods and compositions for modulating splicing
|
|
WO2020163323A1
|
|
Methods and compositions for modulating splicing
|
|
WO2020163409A1
|
|
Methods and compositions for modulating splicing
|
|
WO2020163405A1
|
|
Methods and compositions for modulating splicing
|
|
WO2020163375A1
|
|
Methods and compositions for modulating splicing
|
|
WO2020163248A1
|
|
Methods and compositions for modulating splicing
|
|
EP3781564A1
|
|
Compounds for the treatment of cancer
|
|
WO2019060917A2
|
|
Methods and compositions for screening and identification of splicing modulators
|
|
CN111499615A
|
|
Methods and compositions for modulating splicing
|
